Many technologies are based on scientific principles developed by university laboratories or with public funding (the laser, GPS, or, more recently, the Oxford-AstraZeneca Covid-19 vaccine). Nevertheless, the impact of public research funding on firms has been little documented in a systematic manner. Conversely, public policies supporting private research are analysed, evaluated and documented: for example, the research tax credit was evaluated by the IPP in June 2021.
This is due in particular to the difficulty of identifying the firms that benefit from an increase in (academic) research output in a given field.
Using a new indicator that measures the scientific proximity of firms to research laboratories, the authors of this paper are able to provide a detailed estimate of the impact of an ambitious public research funding programme: the Laboratories of Excellence (LabEx) scheme.
This programme was launched in France in 2010 and has allocated around €1.5 billion to 170 thematic research consortia of researchers.
The authors measure the positive effects of the programme on the R&D expenditure of firms located near these LabEx and active in sectors with a strong scientific proximity to the LabEx’s research theme.
They then examine the channels through which these effects may have been transmitted, enabling the knowledge generated by the LabEx to be disseminated to firms. An analysis of the launch reports for the successful LabEx projects suggests that contractual arrangements between laboratories and firms, as well as the mobility of researchers to firms, play a significant role; this is confirmed by their causal analysis.
This note is taken directly from an academic working paper (CEPR DP17487).
